Suven Pharmaceuticals Q3 FY25 Results
Suven Pharmaceuticals has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 307.15 Cr
- Quarter-on-Quarter (QoQ) Change: 19.18% (Previous Quarter: Rs. 257.72 Cr )
- Year-on-Year (YoY) Change: 39.73% (Same Quarter Last Year: Rs. 219.82 Cr )
Profitability Metrics
- Net Profit: Rs. 83.29 Cr
- QoQ Profit Change: 1.60% (Previous Quarter: Rs. 81.98 Cr )
- YoY Profit Change: 78.15% (Same Quarter Last Year: Rs. 46.75 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 3.26
- QoQ EPS Change: 0.93% (Previous Quarter: Rs. 3.23)
- YoY EPS Change: 77.17% (Same Quarter Last Year: Rs. 1.84)
Performance Summary
Excellent
Suven Pharmaceuticals did very well, with profits growing faster than sales. This means they're managing costs better.
This analysis provides a snapshot of Suven Pharmaceuticals's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.